Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

NCT07360808 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis (SSc)
Hand Dysfunction

Interventions

DEVICE: Autologous ADRCs injection Combined with Standard Therapy
DRUG: Standard Treatment group

Sponsor

Cytori Therapeutics

Collaborators

[object Object]
[object Object]